Out-of-pocket cap will increase the net price of insulin, CBO tells Senate bill sponsors

[cafead]

via A bill that would cap out-of-pocket insulin costs for the insured at $35 per month remains in limbo as the Congressional Budget Office told the two Senate sponsors of the bill that it will likely increase net prices for insulin, and will increase premiums for commercial health insurance and Medicare Part D.

article source